Zomedica Corp. (NYSEAMERICAN:ZOM) Director Buys $12,000.00 in Stock

Zomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers acquired 100,000 shares of the business’s stock in a transaction dated Monday, November 11th. The shares were acquired at an average cost of $0.12 per share, with a total value of $12,000.00. Following the acquisition, the director now directly owns 2,425,000 shares of the company’s stock, valued at $291,000. This represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Zomedica Price Performance

Shares of NYSEAMERICAN:ZOM traded up $0.01 on Tuesday, hitting $0.14. 11,470,186 shares of the company traded hands, compared to its average volume of 4,590,538. Zomedica Corp. has a 52 week low of $0.12 and a 52 week high of $0.23. The company has a market capitalization of $134.45 million, a PE ratio of -2.05 and a beta of 1.06.

Institutional Investors Weigh In On Zomedica

A hedge fund recently raised its stake in Zomedica stock. Virtu Financial LLC raised its holdings in Zomedica Corp. (NYSEAMERICAN:ZOM) by 1,585.0% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 168,773 shares of the company’s stock after acquiring an additional 158,757 shares during the quarter. Virtu Financial LLC’s holdings in Zomedica were worth $25,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 8.95% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Noble Financial raised Zomedica to a “strong-buy” rating in a research note on Monday.

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.